HGF and cancer: c-MET, a kinase receptor for Hepatocyte growth factor (HGF), drives tumorigenesis repressing the Raf kinase inhibitory protein (RKIP), whose loss has been reported in many cancer types overexpressing c-MET, including 50% of CRC [224].